Full-Time

Principal Scientist

Drug Substance

Updated on 12/5/2024

Eikon Therapeutics

Eikon Therapeutics

201-500 employees

Biotech startup developing innovative medicines

Biotechnology
Healthcare

Compensation Overview

$178k - $194.8kAnnually

+ Bonus + Equity Compensation

Senior, Expert

Hayward, CA, USA

Positions will move to Millbrae, CA starting mid-2025.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Postdoc fellowship plus 7 years or a PhD plus a minimum of 10 years of relevant experience or a Master’s degree with 12 years of relevant experience in process chemistry and drug substance development.
  • Experience with cGMP manufacturing of drug substances.
  • Proven track record of successful FIH development, process optimization and regulatory submissions.
  • Strong understanding of FDA and EMA regulatory requirements and quality systems.
  • Excellent communication, leadership, and problem-solving skills with hands-on knowledge of analytical methods and quality control processes.
  • Ability to work in a fast-paced, dynamic environment and manage multiple priorities.
  • Strong analytical and problem-solving skills.
  • Commitment to maintaining high quality standards.
Responsibilities
  • Serve as project lead for in-house process development and manufacturing of drug substances and regulatory starting materials for clinical programs in all phases of development.
  • Oversee process development and scale-up activities at CDMOs.
  • Ensure robust and scalable manufacturing processes are in place.
  • Collaborate with cross-functional teams including Research Project Teams, Regulatory Affairs, Quality Assurance, Manufacturing, Supply Chain and Clinical Operations to ensure seamless product development and scale-up.
  • Develop and execute project plans, timelines, and develop project strategy.
  • Ensure all CMC activities comply with regulatory requirements (FDA, EMA, etc.).
  • Prepare and review CMC sections of regulatory submissions, including INDs, NDAs, and BLAs.
  • Interact with regulatory agencies to address CMC-related queries and provide necessary documentation.
  • Identify and manage external partners, including CMOs and CROs, including negotiating contracts and managing vendor performance.
  • Ensure quality and timely delivery of contracted services.
  • May mentor and develop junior staff members.

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that improve and extend life. A key feature of their approach is a proprietary single-molecule tracking (SMT) platform that visualizes protein motion in living cells, enabling precise inventory of molecular interactions. Eikon Therapeutics aims to serve patients with serious diseases by developing effective treatments and generates revenue through the commercialization of these therapies.

Company Stage

Series C

Total Funding

$750.8M

Headquarters

Hayward, California

Founded

2019

Growth & Insights
Headcount

6 month growth

7%

1 year growth

11%

2 year growth

59%
Simplify Jobs

Simplify's Take

What believers are saying

  • Eikon's recent acquisition of global rights to clinical-stage assets and a robust drug development pipeline positions it for significant growth and market impact.
  • The company's strategic partnerships, such as with Impact Therapeutics for PARP1 selective inhibitors, enhance its capabilities in developing targeted cancer therapies.
  • Eikon's expansion into a new 36,284-square-foot office space in Jersey City reflects its growth and commitment to scaling operations.

What critics are saying

  • The highly competitive biotech and pharmaceutical sectors require continuous innovation to maintain a competitive edge.
  • The integration of newly acquired assets and technologies may pose challenges in terms of operational alignment and resource allocation.

What makes Eikon Therapeutics unique

  • Eikon Therapeutics leverages proprietary single-molecule tracking (SMT) technology to visualize protein motion in living cells, setting it apart from competitors who rely on static snapshots of chemical processes.
  • The integration of advanced automation and artificial intelligence allows Eikon to inventory molecular interactions with unprecedented scale and precision.
  • Eikon's diverse team of scientists, engineers, and clinicians enables a multidisciplinary approach to drug development, enhancing innovation and problem-solving capabilities.

Help us improve and share your feedback! Did you find this helpful?